Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder

Christopher Pittenger; John H. Krystal; Vladimir Coric

doi:10.1016/j.nurx.2005.12.006

Home SearchPaper Details

Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder

Christopher Pittenger, John H. Krystal, Vladimir Coric

Springer Nature (2006) • Volume 3, Issue 1, Pages 69-81

PDF Available

Quick Actions

Read Full Paper

Publication Info

DOI

10.1016/j.nurx.2005.12.006

Language

English

Topic

Obsessive-Compulsive Spectrum Disorders

Keywords

Riluzole, Glutamate receptor, Obsessive compulsive, Glutamatergic, Medicine, Amyotrophic lateral sclerosis, Neurology, Neuroscience, Psychiatry, Psychology, Disease, Internal medicine

Published

January 1, 2006

Citations

220 citations

FWCI

25.13

External Resources

DOI Link OpenAlex

Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder

Quick Actions

Publication Info

External Resources

Suggested Papers

The Role of Polyphenols in Abiotic Stress Tolerance and Their Antioxidant Properties to Scavenge Reactive Oxygen Species and Free Radicals

Dual blockade immunotherapy targeting PD-1/PD-L1 and CTLA-4 in lung cancer

Insulin Resistance and Alzheimer’s Disease: Bioenergetic Linkages

Suggested Papers

Suggested Papers

The Role of Polyphenols in Abiotic Stress Tolerance and Their Antioxidant Properties to Scavenge Reactive Oxygen Species and Free Radicals

Dual blockade immunotherapy targeting PD-1/PD-L1 and CTLA-4 in lung cancer

Insulin Resistance and Alzheimer’s Disease: Bioenergetic Linkages